The 5th most cited journal in Immunology
NK cell and Innate Lymphoid Cell Biology aims to attract submissions focusing on the molecular, cellular and functional aspects of the innate lymphoid cell (ILC) spectrum, which encompasses both cytotoxic (natural killer, NK) and cytokine-producing ILCs as well as their progenitors. This Section of Frontiers in Immunology is dedicated to the analysis of all aspects of ILC biology at all scales, from molecules to the whole organism, in humans and other animal models. More specifically the topics to be covered include:
1) Developmental relationships and plasticity among different ILCs;
2) ILC differentiation, acquisition, and regulation of effector function;
2) Cell surface receptors and their ligands: identification, structure, regulation and functions;
3) Roles of ILCs in the context of microbial infections, tumor development, inflammation, auto-immunity, allergy and metabolic disorders;
4) ILC-based therapies, including cytotoxic NK cell therapies;
5) Monitoring of ILCs in disease conditions.
Indexed in: PubMed, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), EMBASE, Semantic Scholar, Ulrich's Periodicals Directory, CLOCKSS, EBSCO, OpenAIRE, Zetoc
PMCID: all published articles receive a PMCID
NK and Innate Lymphoid Cell Biology welcomes submissions of the following article types: Case Report, Classification, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Protocols, Review, Specialty Grand Challenge, Systematic Review and Technology Report.
All manuscripts must be submitted directly to the section NK and Innate Lymphoid Cell Biology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section NK and Innate Lymphoid Cell Biology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Immunology.